OTC Markets EXMKT - Delayed Quote USD

Hard to Treat Diseases Inc. (HTDS)

0.0000

(0.00%)

At close: December 13 at 3:00:00 PM EST

How AI energy demand in 2025 will put natural gas in the spotlight

Oil and gas are on track to end the year in negative territory. But in 2025, keep an eye out on natural gas as electricity demand rises.

Yahoo Finance 2 hours ago

WMB

OKE

GEV
1 Stock to Buy, 1 Stock to Sell This Week: Micron, Nike

• Fed rate cut, FOMC dot-plot, Powell comments will be in focus this week. • Micron offers significant upside potential backed by robust earnings growth and strong demand for its AI-related products. • Nike faces mounting challenges, with declining revenues, a cautious outlook, and soft consumer demand suggesting further downside for its stock price. • Looking for more actionable trade ideas? Subscribe here for 55% off InvestingPro as part of our Cyber Week Extended sale! U.S. stocks closed most

Investing.com 3 hours ago

MU

NKE

^GSPC
The Ultimate Oil Stock to Buy With $200 Right Now

Warren Buffet has one of the best investing track records of all time. If you want to find profitable investments, just pay attention to Buffett's portfolio. In fact, it's possible that Buffett will eventually buy the entire company.

Motley Fool 4 hours ago

OXY

^GSPC
Jim Cramer Says He Was Wrong on NVIDIA Holding Recursion Pharmaceuticals (RXRX)

We recently published a list of Jim Cramer’s Latest Calls: Top 10 Stocks. In this article, we are going to take a look at where Recursion Pharmaceuticals Inc (NASDAQ:RXRX) stands against other stocks highlighted in Jim Cramer’s latest calls. Jim Cramer in a recent program talked about Bitcoin and reminded investors that he has always […]

Insider Monkey 4 hours ago

RXRX

NVDA
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

It's been a good year for the stock market as a whole and a tremendous year for a couple of drugmaker start-ups. BTIG analyst Justin Zelin thinks Viking Therapeutics stock can reach $125 per share for a gain of about 166% over the next 12 months. If an experimental weight loss treatment it's developing continues to succeed in clinical trials, the stock could more than double again.

Motley Fool 4 hours ago

VKTX

SMMT
Oppenheimer Predicts Up to ~580% Jump for These 2 ‘Strong Buy’ Stocks

It’s safe to say that stock investors are closing out 2024 in a rather upbeat mood. The markets posted substantial gains, with the S&P 500 surging nearly 27% year-to-date. The support for the current bullish trend is clear. The prospect of interest rate cuts, coupled with stronger-than-expected corporate earnings, is driving market confidence. Adding to the bullish outlook, last month’s election saw former President Trump secure a non-consecutive second term, fueling hopes for a pro-business, pr

TipRanks 6 hours ago

YMAB

SGMT
1 Stock With Monster Upside to Buy as the AI Trade Enters Its Next Phase in 2025, According to Wall Street Analysts

Jim Tierney at AllianceBernstein recently told Yahoo Finance that chipmakers like Nvidia were the first phase of the artificial intelligence (AI) trade. Numerous companies should benefit as the trend takes shape, but Cloudflare (NYSE: NET) is one investors may overlook because it receives less media coverage than the "Magnificent Seven" companies. Here's what investors should know about this cloud infrastructure stock.

Motley Fool 7 hours ago

NET

NVDA

MSFT
What Wall Street Analysts Think of Micron's Stock Ahead of Earnings

Micron Technology is set to report earnings after the market closes Wednesday, with analysts overwhelmingly bullish on the chipmaker's stock.

Investopedia 7 hours ago

MU
Micron, Nike, FedEx, and more stocks to watch this week

The Christmas holiday is fast approaching, and the festive spirit is in full swing as people gear up for celebrations, shopping sprees, and family reunions. While only a few companies are set to release earnings reports this week, the stock market is bracing for a potentially pivotal moment. This week, the Federal Reserve is expected to announce whether it will lower interest rates—a decision that could significantly influence the economic and financial landscape heading into 2025.

Quartz 7 hours ago

MU

NKE

FDX
What To Expect in the Markets This Week

Coming up: Fed interest rate decision, Powell remarks, PCE inflation report, earnings from Micron, Nike, FedEx, Carnival

Investopedia 7 hours ago

MU

NKE

FDX
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

While chipmaker Nvidia is an obvious example of a top growth stock to own given its more than 2,500% return over the past five years, there are many other stocks that have produced incredible gains in a short stretch. Three stocks that have done phenomenally well this year and have outperformed Nvidia are AppLovin (NASDAQ: APP), MicroStrategy (NASDAQ: MSTR), and Summit Therapeutics (NASDAQ: SMMT). If you invested $5,000 into each one of these stocks at the beginning of the year, the total of those investments would be worth more than $100,000 right now.

Motley Fool 20 hours ago

APP

MSTR

NVDA
Cloudflare price target raised to $125 from $102 at Mizuho

Mizuho analyst Gregg Moskowitz raised the firm’s price target on Cloudflare (NET) to $125 from $102 and keeps a Neutral rating on the shares as part of a 2025 outlook for the software group. The firm increased price targets on several companies, largely a reflection of recent increases in comp multiples. It believes the most important trends benefiting software vendors today and in the future are digital transformation, generative artificial intelligence, data and analytics, contact center cloud

TipRanks yesterday

NET
Here's 1 Stock Warren Buffett Could Be Buying Hand Over Fist Before the End of 2024

Warren Buffett is sitting on the sidelines for the most part. Would it be surprising if Buffett didn't buy any stocks in the fourth quarter of this year? Here's one stock Buffett could be buying hand over fist before the end of 2024.

Motley Fool yesterday

OXY
10 Top Stocks to Buy in 2025

Amazon (NASDAQ: AMZN) is a no-brainer stock for almost any portfolio, and even though it's already the second-largest company in the U.S. by sales, it has so much more potential. It represents about 37% of all U.S. e-commerce and has 33% of the global cloud computing market, both of which make it unstoppable. Sadly, I removed American Express (NYSE: AXP) from my list last year and lost out on its incredible gains in 2024.

Motley Fool yesterday

AXP

CUK

NU
Could Buying SoFi Stock Today Set You Up for Life?

Could SoFi stock set you up for life? CEO Anthony Noto has the ambitious goal of SoFi becoming a top-10 bank, and if it continues to grow the way it is right now, that could eventually happen. Another benefit of the expansion strategy is that it's leading to scale, and SoFi has reported positive net income for four consecutive quarters.

Motley Fool yesterday

SOFI
Jim Cramer Says ‘Both Micron Technology, Inc. (MU) and ADI Are Well Off Their High, So The Whole Thing Might Be A Bit Of A Comedown For Them’

We recently compiled a list of the Jim Cramer Discussed 18 Companies That Hit $100 Billion in Market Cap in 2024. In this article, we are going to take a look at where Micron Technology, Inc. (NASDAQ:MU) stands against the other companies that hit $100 billion in market cap in 2024. Jim Cramer, the host of […]

Insider Monkey yesterday

MU
Nike earnings, Fed meeting, Nov. PCE: What to Watch

Market Domination Overtime Hosts Julie Hyman and Josh Lipton detail the top market headlines to watch for next week. All eyes are on the Federal Reserve as the Federal Open Market Committee (FOMC) prepares for its December 17-18 meeting. Wall Street is closely monitoring the central bank's upcoming interest rate decision, with markets currently pricing in an expected 25 basis point cut. A slew of earnings reports are scheduled for release, featuring companies including Nike (NKE), Micron (MU), General Mills (GIS), Lennar (LEN), FedEx (FDX), and Accenture (ACN). On the economic calendar, two key releases are due: November's Personal Consumption Expenditures (PCE) index— the Fed's preferred measure of inflation —will be released on Friday, while Retail Sales data will be published earlier in the week. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith

Yahoo Finance Video yesterday

LEN

LEN-B

FDX
As stocks push higher, market breadth continues to deteriorate

The S&P 500's (^GSPC) market breadth has been deteriorating, signaled by select stock leaders continuing to carry the index's gains. Yahoo Finance host Julie Hyman examines the latest data out from Bespoke Investment Group, referring back to RBC Capital Markets equity derivatives strategist Amy Wu Silverman's comments to Yahoo Finance earlier today on this trend as Wall Street expects Big Tech growth to broaden out across the market in 2025. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video yesterday

^SPX

^GSPC
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, December 13, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 98,000 shares of common stock. Awards were made to six new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committe

Business Wire yesterday

SMMT
Workday Stock Joins The 95-Plus Composite Rating Club

Workday stock saw an improvement in its IBD SmartSelect Composite Rating Friday, from 94 to 97. The upgrade means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. Is Workday Stock A Buy?

Investor's Business Daily yesterday

NOW

NET

WDAY

Performance Overview

Return	HTDS	S&P 500
YTD	0.00%	+26.86%
1-Year	0.00%	+30.31%
3-Year	0.00%	+28.42%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hard to Treat Diseases Inc. (HTDS)

Related News

How AI energy demand in 2025 will put natural gas in the spotlight

1 Stock to Buy, 1 Stock to Sell This Week: Micron, Nike

The Ultimate Oil Stock to Buy With $200 Right Now

Jim Cramer Says He Was Wrong on NVIDIA Holding Recursion Pharmaceuticals (RXRX)

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Oppenheimer Predicts Up to ~580% Jump for These 2 ‘Strong Buy’ Stocks

1 Stock With Monster Upside to Buy as the AI Trade Enters Its Next Phase in 2025, According to Wall Street Analysts

What Wall Street Analysts Think of Micron's Stock Ahead of Earnings

Micron, Nike, FedEx, and more stocks to watch this week

What To Expect in the Markets This Week

Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

Cloudflare price target raised to $125 from $102 at Mizuho

Here's 1 Stock Warren Buffett Could Be Buying Hand Over Fist Before the End of 2024

10 Top Stocks to Buy in 2025

Could Buying SoFi Stock Today Set You Up for Life?

Jim Cramer Says ‘Both Micron Technology, Inc. (MU) and ADI Are Well Off Their High, So The Whole Thing Might Be A Bit Of A Comedown For Them’

Nike earnings, Fed meeting, Nov. PCE: What to Watch

As stocks push higher, market breadth continues to deteriorate

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Workday Stock Joins The 95-Plus Composite Rating Club

Performance Overview